[1] TAN DX, HARDELAND R.Targeting host defense system and rescuing compromised mitochondria to increase tolerance against pathogens by melatonin may impact outcome of deadly virus infection pertinent to COVID-19[J]. Molecules, 2020, 25(19): 4410. [2] GU H, FADA BJ.Specificity in ubiquitination triggered by virus infection[J]. Int J Mol Sci, 2020, 21(11): 4088. [3] TRILLA A, TRILLA G, DAER C.The 1918 "Spanish flu" in Spain[J]. Clin Infect Dis, 2008, 47(5): 668-673. [4] CHEN BC, CHEN LS.Research status and development trend of antiviral drugs[J]. Herald of Medicine(医药导报), 2011, 30(9): 1119-1124. [5] YU HC, ZHANG W, JIN XL, et al.Analysis of 97 cases of adverse drug reactions induced by thioctic acid injection and its related factors[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(4): 52-55,59. [6] Chinese Pharmacopoeia Commission.Pharmacopoeia of People's Republic of China 2020 (中华人民共和国药典2020年版), Vol Ⅱ[M] Vol Ⅱ[M]. Beijing: China Medical Science Press, 2020. [7] U.S.Pharmacopoeia Convention. U.S. Pharmacopoeia 43[M]. The United States Pharmacopeial Convention, 2020. [8] European Pharmacopoeia Commission.European Pharma-copoeia[M]. 10.0 edition. Strasbourg: European Directorate for Quality Medicines, 2019. [9] Pharmaceuticals and Medical Devices Agency of Japan. The Japanese Pharmacopoeia[M]. 17th ed. Tokyo: the Ministry of Health, Labor and Welfare, 2016. [10] LO MK, FELDMANN F, GARY JM, et al. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge[J]. Sci Transl Med, 2019, 11(494): eaau9242. [11] LAMB YN.Remdesivir: first approval[J]. Drugs, 2020, 80(13): 1355-1363. [12] ZHANG ST, NI MX, RUAN QP.Enzymatic synthesis of nucleotide drugs[J]. Progress in Pharmaceutical Sciences(药学进展), 2005, 29(2): 56-62. [13] WANG L, BUCHANAN S, MEYERHOFF ME.Detection of high-charge density polyanion contaminants in biomedical heparin preparations using potentiometric polyanion sensors[J]. Anal Chem, 2008, 80(24): 9845-9847. [14] HU CQ.Developments on analysis of polymers of B-lactam antibiotics[J]. Chinese Journal of New Drugs(中国新药杂志), 2008, 17(24): 2098-2102. [15] OUYANG Q, SHEN XX.HPLC determination of emtricitabine enantiomer by chirality column[J]. Chin J Pharm Anal(药物分析杂志), 2007, 27(11): 1698-1700. [16] ZHU GG.Determination of the related substances in vidarabine monophosphate for injection by HPLC[J]. Evaluation and Analysis of Drug-use in Hospitals of China(中国医院用药评价与分析), 2015, 15(7): 857-859. [17] JIAO XW, LIANG WY.Determination of related substances in vidarabine monophosphate for injection by HPLC[J]. China Pharmacist(中国药师), 2015, 18(4): 652-655. [18] BAKER MM, HAMMAD SF, BELAL TS.Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies[J]. Drug Dev Ind Pharm, 2019, 45(7): 1111-1119. [19] ICH steering committee. ICH harrnonised tripartite guideline:Impurities in new drug products: Q3B (R2) [EB/OL]. (2006-06)[2021-08-31].https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-3-b-r2-impurities-new-drug-products-step-5_en.pdf.[20] GAO M, YAN XD, JIN SZ, et al. Application of liquid chromatography-mass spectrometry in drug related substances analysis[J]. Drug Evaluation Research(药物评价研究), 2012, 35(1): 63-66. [21] TAO L, HUANG F, SONG WF, et al.Determination of related substances in entecavir oral preparation by liquid chromatography-tandem mass spectrometry[J]. Journal of Instrumental Analysis(分析测试学报), 2014, 33(3): 362-366. [22] CHEN D, KANG LJ, ZHANG L, et al.Determination of 9-propenyladenine in tenofovir disoproxil fumarate by LC-MS[J]. Chinese Journal of Pharmaceuticals(中国医药工业杂志), 2014, 45(10): 959-961. [23] AL AZZAM KM, SAAD B, MAKAHLEAH A, et al.Assay and stability-indicating micellar electrokinetic chromatography method for the simultaneous determination of valacyclovir, acyclovir and their major impurity guanine in pharmaceutical formulations[J]. Biomed Chromatogr, 2010, 24(5): 535-543. [24] CARVALHO AZ, EL-ATTUG MN, ZAYED SE, et al.Micellar electrokinetic chromatography method development for determination of impurities in ritonavir[J]. J Pharm Biomed Anal, 2010, 53(5): 1210-1216. [25] ZHAO R.UPLC in pharmaceutical analysis[J]. Heilongjiang Medicine Journal(黑龙江医药), 2014, 27(2): 283-285. [26] CHU WM.Study of UPLC method on related substances in aciclovir[J]. Guangzhou Chemical Industry(广州化工), 2015, 43(23): 172-175. [27] SHEN J, WU QH, CHEN YH, et al.Drug use and transfusion safety of blood donors[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(4): 249-252, 256. [28] US Food and Drug Administration. Liquid chromatography-high resolution mass spectrometry (LC-HRMS) method for the determination of six nitrosamine impurities in ARB drugs[EB/OL]. (2019-05-21)[2021-08-31]. https://www.fda.gov/media/125478/download. [29] LIU KL, LIANG JW, WANG S, et al.Study on the quantitative structure-genetic toxicity relationships of pyrrolizidine alkaloids[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(6): 321-324. [30] LIU X, LI C, HAN H, et al.Advances on genotoxic impurities of sulfonate esters in pharmaceuticals[J]. J Se Pu, 2018, 36(10): 952-961. [31] SZEKELY G, AMORES DSM, GIL M, et al.Genotoxic impurities in pharmaceutical manufacturing: sources, regulations, and mitigation[J]. Chem Rev, 2015, 115(16): 8182-8229. [32] WUTZLER P, THUST R.Genetic risks of antiviral nucleoside analogues--a survey[J]. Antiviral Res, 2001, 49(2): 55-74. [33] JIANG L, WU X, HE F, et al.Genetic evidence for genotoxic effect of entecavir, an anti-hepatitis B virus nucleotide analog[J]. PLoS One, 2016, 11(1): e0147440. [34] VENUGOPAL N, VIJAYA BRA, MADHAVI G.Development and validation of a systematic UPLC-MS/MS method for simultaneous determination of three phenol impurities in ritonavir[J]. J Pharm Biomed Anal, 2014, 90: 127-133. [35] KAKADIYA PR, REDDY BP, SINGH V, et al.Low level determinations of methyl methanesulfonate and ethyl methanesulfonate impurities in lopinavir and ritonavir active pharmaceutical ingredients by LC/MS/MS using electrospray ionization[J]. J Pharm Biomed Anal, 2011, 55(2): 379-384. [36] KAKADIYA PR, CHANDRASHEKHAR TG, GANGULY S.Low level determinations of methyl methanesulfonate and ethyl methanesulfonate impurities in emtricitabine active pharmaceutical ingredient by LC/MS/MS using electrospray ionization[J]. Anal Chem Insights, 2011, 6: 21-28. [37] LIU B, ZHANG T, HUANG L, et al.Determination of 7 N- nitrosoamines in metformin hydrochloride sustained release tablets by LCHRMS[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(5): 454-458, 468. [38] HU CQ.Current status and prospects of chemical impurity control[J]. SCIENTIA SINICA Chimica(中国科学:化学), 2010, 40(6): 679-687. |